These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17403471)

  • 1. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mechanical circulatory support on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Gilbert EM; Moore SA; Campbell BK; Nelson KE; Horne BD; Renlund DG
    J Heart Lung Transplant; 2006 Jan; 25(1):22-8. PubMed ID: 16399526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
    Torres Macho J; Delgado Jimenez JF; Sanz Salvo J; Gonzalez Mansilla A; Sanchez Sanchez V; Gamez Diez S; Escribano Subias P; Saenz de la Calzada C
    Transplant Proc; 2009; 41(6):2477-9. PubMed ID: 19715956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
    J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
    Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
    G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?
    Patel ND; Williams JA; Nwakanma LU; Waldron MM; Bluemke DA; Conte JV
    Ann Thorac Surg; 2006 Sep; 82(3):879-88; discussion 888. PubMed ID: 16928501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?
    Takayama H; Nathens AB; Merry H; Aldea GS; Fishbein DP; Verrier ED; Salerno CT
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):457-61. PubMed ID: 17267233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Russell SB; Conte JV; Shah AS
    J Heart Lung Transplant; 2008 Feb; 27(2):178-83. PubMed ID: 18267224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database.
    Patel ND; Weiss ES; Nwakanma LU; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circulation; 2008 Sep; 118(14 Suppl):S83-8. PubMed ID: 18824775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.